Recap: Top 10 Antitrust Issues in 2023

Throughout 2023, Antitrust Byte covered a variety of antitrust issues that should be top of mind for stakeholders in the health care industry.

In case you missed any, below are the top 10 issues from last year, with links to each of the related Antitrust Bytes:

1. Additional Withdrawals of Long-Standing Guidance and Newly Proposed Merger Guidelines
2. FTC Warns Against Contract Provisions It Believes Could Impede Its Investigations
3. A 20-Year Consent Order Prohibiting the Use of Non-Compete Agreements
4. Accompanying Statements to Hart-Scott-Rodino Annual Report Exemplify Ongoing Tension at FTC
5. FTC’s Fight with House Judiciary Committee Goes Public
6. Supreme Court Determines That Constitutionality of FTC’s Administrative Review Process Can Be Challenged in Federal District Court
7. New Antitrust Theory: Cross-Market Effects
8. Are Conduct Remedies to Merger Challenges Back on the Table?
9. New HSR Filing Fee Tier System in Effect
10. DOJ’s Antitrust Division Continues Its Pursuit of Overlapping Directorates

* * *

For additional information about the issues discussed in this Antitrust Byte, or if you have any other antitrust concerns, please contact the attorneys listed on this page or the Epstein Becker Green attorney who regularly handles your legal matters.